WebApr 22, 2024 · Endeavour Vision is a venture capital and growth equity firm founded in 2000, that invests in growth-stage medtech and digital health companies in Europe and the US. Its international investment teams are based in two global healthcare hubs in Geneva, Switzerland, and Minneapolis, US. WebApr 22, 2024 · The EMG II LP fund will continue the strategy of its US$250 million predecessor (Endeavour Medtech Growth LP) by investing in high-potential European and US companies delivering transformative healthcare technologies to improve the standard of care for patients and bring efficiencies to healthcare systems. In particular, the fund will …
Endeavour Vision closes Endeavour Medtech Growth II LP at …
WebMar 22, 2016 · Healthcare investor Endeavour Vision said today it it will shift its focus to medtech after raising $275 million (€250 million) in committed capital for its Endeavour … WebWe are dedicated to supporting the growth of medtech companies across Europe and the United States. ... Endeavour Vision is the clear partner of choice to help both entrepreneurs and investors succeed in transforming medical care. "As a trusted Board Member and Partner, Endeavour Vision brings a wealth of operational and financial experience to ... col joe bookard
Endeavour Medtech Growth II Profile: Investments
WebIncludes (i) 2,203,965 shares of Class A common stock held by Endeavour Medtech Growth II LP and (ii) 39,670 shares of Class A common stock held by Endeavour Medtech Growth Parallel II LP. (2) Consists of 34,449,144 shares of Class A Common Stock of the Issuer outstanding on November 1, 2024, based on information publicly disclosed by the … WebApr 22, 2024 · Endeavour Medtech Growth II General Information. Description. Endeavour Medtech Growth II is a 2024 vintage venture capital fund managed by Endeavour Vision. … WebApr 22, 2024 · Endeavour Vision closes Endeavour Medtech Growth II LP at USD 375m to invest in transformative healthcare technologies. Written by Ken Dropiewski on April 22, 2024. More in Financial: Bellerophon Provides Clinical Program Update and Reports Full-Year 2024 Financial Results March 31, 2024; col joel newsom